Try our beta test site

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Somnarus Inc
Information provided by (Responsible Party):
Somnarus Inc Identifier:
First received: January 9, 2014
Last updated: April 13, 2016
Last verified: April 2016
The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).

Obstructive Sleep Apnea
Central Sleep Apnea
Mixed Sleep Apnea
Cheyne-Stokes Respiration

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Comparison of the Somnarus Sleep Apnea Diagnostic Technology SomnaPatch With Polysomnography in Sleep Disordered Breathing

Resource links provided by NLM:

Further study details as provided by Somnarus Inc:

Primary Outcome Measures:
  • Apnea-Hypopnea Index [ Time Frame: 1 month ]

Estimated Enrollment: 60
Study Start Date: January 2014
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   20 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient who have been diagnosed with sleep disordered breathing (apnea or Cheyne-Stokes respiration)

Inclusion Criteria:

  • Able to understand and sign the informed consent
  • Able to comply with visits and follow ups included in this protocol
  • Ages 20-85 years

Exclusion Criteria:

  • An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
  • Skin rash on the nose or on the maxillary area.
  • A history of skin allergy to medical tape, and hypoallergenic tapes.
  • A history of skin cancer on the nose or on the maxillary area.
  • A history of the base of skull fractures, facial fractures
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02034175

Contact: Maria Merchant, PhD 408-761-0884

United States, California
Peninsula Sleep Center Recruiting
Burlingame, California, United States
Contact: Juliann Nealon, MD    650-636-9396      
Principal Investigator: Mehran Farid-Moayer, MD         
Sponsors and Collaborators
Somnarus Inc
  More Information

Responsible Party: Somnarus Inc Identifier: NCT02034175     History of Changes
Other Study ID Numbers: SomnaPatch-001
Study First Received: January 9, 2014
Last Updated: April 13, 2016

Keywords provided by Somnarus Inc:

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Sleep Apnea, Central
Cheyne-Stokes Respiration
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on March 29, 2017